Louisiana 2012 Regular Session

Louisiana Senate Bill SB485

Introduced
3/12/12  
Refer
3/12/12  
Report Pass
4/17/12  
Engrossed
4/24/12  
Refer
4/25/12  
Report Pass
5/9/12  
Enrolled
5/30/12  
Chaptered
6/7/12  

Caption

Provides relative to certain offenses committed when operating a vehicle while intoxicated. (gov sig)

Impact

The bill's enactment represents a significant shift in how intoxicated driving is prosecuted in Louisiana. By including detectable amounts of controlled substances, this law broadens the scope of offenses that can lead to severe consequences, potentially deterring individuals from driving under the influence of not just alcohol but also various drugs. This could lead to increased law enforcement focus on drugged driving and a reconceptualization of public perception regarding impaired driving incidents.

Summary

Senate Bill 485 amends Louisiana law regarding offenses committed while operating a vehicle under the influence. Specifically, it expands the definitions of vehicular homicide and third-degree feticide to include any incidents in which the driver has any detectable amount of controlled substances present in their blood. This change aims to strengthen the legal consequences for individuals who operate vehicles while impaired by drugs, thus enhancing public safety and potentially reducing traffic fatalities related to intoxication.

Sentiment

Discussions surrounding SB 485 appear to be largely supportive, particularly from advocacy groups concerned with road safety and the prevention of drug-related traffic incidents. However, there may be some contention over the implications of the law regarding how 'detectable amounts' are defined and measured, as this can lead to varied interpretations in different contexts, possibly raising concerns about fairness in enforcement.

Contention

Notably, the bill has raised questions about the scientific basis of measuring controlled substances in a person's blood and how these measurements might affect individuals who have legally prescribed medications. Critics may contend that individuals under medical care could be unfairly prosecuted, leading to discussions about potential exceptions or clarifications needed in the law to protect those individuals.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.